The US Food and Drug Administration (FDA) has approved an orally available ghrelin agonist, macimorelin (Macrilen, Aeterna Zentaris), to be used in the diagnosis of patients with adult growth-hormone ...
News that several New Zealand universities have given up using detection software to expose student use of artificial intelligence (AI) underlines the challenge higher education is facing. Subscribe ...
Vigilant Biosciences roped in $5.5 million in a Series B round to support development of its diagnostic system for the early detection of oral cancer, giving the company a boost as it eyes European ...